Cargando…
The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study
Rome IV bowel disorders of gut brain interaction (DGBI) and non-alcoholic fatty liver disease (NAFLD) are highly prevalent entities with overlapping pathophysiology and risk factors. We aimed to evaluate the prevalence and burden of Rome IV irritable bowel syndrome (IBS) in patients with NAFLD. Pati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229668/ https://www.ncbi.nlm.nih.gov/pubmed/37253969 http://dx.doi.org/10.1038/s41598-023-35774-5 |
_version_ | 1785051317889138688 |
---|---|
author | Purssell, Huw Bennett, Lucy Street, Oliver Hanley, Karen Piper Hanley, Neil Vasant, Dipesh H. Athwal, Varinder S. |
author_facet | Purssell, Huw Bennett, Lucy Street, Oliver Hanley, Karen Piper Hanley, Neil Vasant, Dipesh H. Athwal, Varinder S. |
author_sort | Purssell, Huw |
collection | PubMed |
description | Rome IV bowel disorders of gut brain interaction (DGBI) and non-alcoholic fatty liver disease (NAFLD) are highly prevalent entities with overlapping pathophysiology and risk factors. We aimed to evaluate the prevalence and burden of Rome IV irritable bowel syndrome (IBS) in patients with NAFLD. Patients diagnosed with NAFLD were recruited from a specialist liver clinic. All participants completed assessments to determine liver fibrosis severity, including liver stiffness measurement (LSM), completed the Rome IV diagnostic questionnaire for bowel disorders of gut brain interaction, the IBS symptom severity score (IBS-SSS), and the EQ-5D-5L to measure of quality-of-life (QoL). 142 patients with NAFLD (71 (50%) female, mean age 53.5 (SD ± 14.9), BMI 35.2 (SD ± 8.1) kg/M(2)) were recruited. 79 (55.6%) patients met criteria for a Rome IV bowel DGBI, including 50 patients (35.2%) who met the criteria for IBS (mean IBS-SSS 277.2 (SD ± 131.5)). There was no difference in liver fibrosis scores between those with and without Rome IV IBS (FIB-4 scores p = 0.14, LSM p = 0.68). Patients with NAFLD and Rome IV IBS had significantly worse QoL scores (EQ-VAS p = 0.005 and EQ-5D-5L index p = 0.0007), impairment of usual activities of daily living (p = 0.012) and were more likely to report anxiety or depression (p = 0.038). Rome IV bowel DGBI such as IBS are highly prevalent in patients with NAFLD attending liver clinics and are associated with impaired QoL and psychosocial distress. |
format | Online Article Text |
id | pubmed-10229668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102296682023-06-01 The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study Purssell, Huw Bennett, Lucy Street, Oliver Hanley, Karen Piper Hanley, Neil Vasant, Dipesh H. Athwal, Varinder S. Sci Rep Article Rome IV bowel disorders of gut brain interaction (DGBI) and non-alcoholic fatty liver disease (NAFLD) are highly prevalent entities with overlapping pathophysiology and risk factors. We aimed to evaluate the prevalence and burden of Rome IV irritable bowel syndrome (IBS) in patients with NAFLD. Patients diagnosed with NAFLD were recruited from a specialist liver clinic. All participants completed assessments to determine liver fibrosis severity, including liver stiffness measurement (LSM), completed the Rome IV diagnostic questionnaire for bowel disorders of gut brain interaction, the IBS symptom severity score (IBS-SSS), and the EQ-5D-5L to measure of quality-of-life (QoL). 142 patients with NAFLD (71 (50%) female, mean age 53.5 (SD ± 14.9), BMI 35.2 (SD ± 8.1) kg/M(2)) were recruited. 79 (55.6%) patients met criteria for a Rome IV bowel DGBI, including 50 patients (35.2%) who met the criteria for IBS (mean IBS-SSS 277.2 (SD ± 131.5)). There was no difference in liver fibrosis scores between those with and without Rome IV IBS (FIB-4 scores p = 0.14, LSM p = 0.68). Patients with NAFLD and Rome IV IBS had significantly worse QoL scores (EQ-VAS p = 0.005 and EQ-5D-5L index p = 0.0007), impairment of usual activities of daily living (p = 0.012) and were more likely to report anxiety or depression (p = 0.038). Rome IV bowel DGBI such as IBS are highly prevalent in patients with NAFLD attending liver clinics and are associated with impaired QoL and psychosocial distress. Nature Publishing Group UK 2023-05-30 /pmc/articles/PMC10229668/ /pubmed/37253969 http://dx.doi.org/10.1038/s41598-023-35774-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Purssell, Huw Bennett, Lucy Street, Oliver Hanley, Karen Piper Hanley, Neil Vasant, Dipesh H. Athwal, Varinder S. The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
title | The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
title_full | The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
title_fullStr | The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
title_full_unstemmed | The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
title_short | The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
title_sort | prevalence and burden of rome iv bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229668/ https://www.ncbi.nlm.nih.gov/pubmed/37253969 http://dx.doi.org/10.1038/s41598-023-35774-5 |
work_keys_str_mv | AT purssellhuw theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT bennettlucy theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT streetoliver theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT hanleykarenpiper theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT hanleyneil theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT vasantdipeshh theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT athwalvarinders theprevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT purssellhuw prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT bennettlucy prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT streetoliver prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT hanleykarenpiper prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT hanleyneil prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT vasantdipeshh prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy AT athwalvarinders prevalenceandburdenofromeivboweldisordersofgutbraininteractioninpatientswithnonalcoholicfattyliverdiseaseacrosssectionalstudy |